arrow
M

Markus Gerhard

nih national cancer institute (nci)
H指数:51
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metronidazole and ether derivatives target Helicobacter pylori via simultaneous stress induction and inhibition

甲硝唑和醚衍生物通过同时诱导和抑制压力来靶向幽门螺杆菌

2026-03-180
OAAI
Helicobacter pylori Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group Report

幽门螺杆菌筛查与治疗计划用于胃癌预防——国际癌症研究机构工作组报告

2026-03-124
PRE
Impact of Helicobacter pylori on Immune Checkpoint Inhibition in Hepatocellular Carcinoma: A Multicenter Study
2025-02-190
PRE
Gut microbiome alterations precede graft rejection in kidney transplantation patients

肠道微生物组改变先于肾移植患者中的移植物排斥。

2025-02-180
OAAI
Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial
2024-07-304
PRE
A multiserological line assay to potentially discriminate current from past Helicobacter pylori infection

一种多血清学检测方法,可将当前的幽门螺杆菌感染与过去的幽门螺杆菌感染区分开

2024-01-010
PRE
CagA-specific Gastric CD8D Tissue-Resident T Cells Control Helicobacter pylori During the Early Infection Phase

CagA特异性胃CD8D组织驻留T细胞在早期感染阶段控制幽门螺杆菌

2023-04-0119
OA
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers
2023-02-142
OAAI
Functional antagonism between CagA and DLC1 in gastric cancer
2022-08-132
OAAI
Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
2022-01-1045
OAAI
Recruitment of highly cytotoxic CD8+ T cell in mild SARS-CoV-2 infection
2022-01-0122
OAAI